
New Research on the Effects of Secondhand Smoke in Youth
Several new studies highlight the harmful effects
of secondhand smoke in children. The researchers in the studies
stress the need for parents to protect the health of their children
and take measures to prevent exposure to secondhand smoke. These
studies, while focused on secondhand smoke exposure in children,
underscore the critical need for increasing consumer demand for
cessation among parents and caregivers and highlight the importance
of the work being done by NTCC and its members.
One new study found that children exposed to secondhand
smoke often have levels of carbon monoxide in their blood that
are similar to those of adult smokers, and frequently higher levels
than adults exposed to secondhand smoke.
The study, presented this month at the American
Society of Anesthesiologists annual meeting, found that the younger
the child, the greater the potential level of exposure.
The study measured levels of carboxyhemoglobin,
which is formed when carbon monoxide binds to the blood, in 200
children between the ages of 1 and 12. The exact ramifications
of high levels of carboxyhemoglobin are not entirely known, but
long-term, low-level exposure includes changes in heart and lung
tissue as it hampers delivery of oxygen to body tissue.
While household and environmental factors such as
stoves, heaters and automobiles are potential sources of carbon
monoxide exposure, secondhand cigarette smoke is often the most
likely source of elevated carboxyhemoglobin, the researchers said.
Dr. Branden E. Yee, of the anesthesiology department
at Tufts Medical Center in Boston, said educating parents about
the need to change their smoking habits, especially around children,
is vital.
For more information on this study, please see the
Washington
Post, October 20, 2008.
Other new research suggests that exposure to second-hand
smoke may actually lead to symptoms of nicotine dependence in
youth who have never before had a cigarette.
The findings are published in the September edition
of the journal Addictive Behaviors in a joint study from
nine Canadian institutions.
Increased exposure to second-hand smoke, both in
cars and homes, was associated with an increased likelihood of
children reporting nicotine dependence symptoms, even though these
children had never smoked," the researchers reported.
"According to conventional understanding, a person
who does not smoke cannot experience nicotine dependence," says
Mathieu Bélanger, the study's lead author and the new research
director of the Centre de Formation Médicale du Nouveau-Brunswick
of the Université de Moncton and Université de Sherbrooke. "Our
study found that 5 percent of children who had never smoked a
cigarette, but who were exposed to secondhand smoke in cars or
their homes, reported symptoms of nicotine dependence."
"Like many other studies before, this one is giving
a sign to parents not to smoke around their children," Belanger
said.
For more information on this study, please see
ScienceDaily,
September 30, 2008.
Other new research supports the link between secondhand
smoke exposure and asthma in children.
The study, published in the October 16 issue of
the New England Journal of Medicine, found that certain
genetic variations previously identified as putting people at
higher risk for asthma apparently only increase the risk of so-called
early-onset asthma, which is disease that appears at 4 years of
age or younger. The risk is further increased by exposure to secondhand
smoke in early life.
A previous, genome-wide association study found
that certain genetic variations were linked to a heightened risk
of asthma. This study found that was an even stronger association
between six variants in a particular chromosome and asthma in
people who had been exposed to secondhand smoke at an early age
-- an almost threefold increase in risk in children with the genetic
variant and early exposure to smoke.
Dr. Len Horovitz, a pulmonary specialist with Lenox
Hill Hospital in New York City said "wat was interesting [about
these findings] was the interlude between nature and nurture.
It's clear that those kids exposed to secondhand smoke had much
more of a flowering of the disease process than those who weren't.
That illustrates that while something can be genetically determined,
it can be amplified by environmental factors."
For more information on this study, please see
U.S.
News and World Report,
October 15, 2008.
While these studies confirm and reinforce how harmful
effects of secondhand smoke exposure in children, a study from
Johns Hopkins Children's Center study suggests that pediatricians
may be getting a skewed idea about their patients' exposure to
secondhand smoke. A recent study found that the parents and caregivers
of children with asthma often underestimate and underreport how
much they smoke at home and around their children.
In a study of 81 children with persistent asthma
who lived with a smoker, researchers found wide discrepancies
between objective tests and parental reports. In addition, nearly
one-third of parents and caregivers reported smoking in the car
in the child's presence, a red flag that exposure to secondhand
smoke occurs outside the home.
Because self-reporting inaccurately gauges exposure,
pediatricians should use more reliable measures such as obtaining
urine samples from children to check for secondhand smoke inhalation,
researchers say.
"We want pediatricians caring for children with
asthma to keep in mind that a child's symptoms could be brought
on by secondhand smoke," said lead investigator Arlene Butz.
For more information on this study, please see the
JHU Gazette, October 13, 2008.
The findings from these recent studies highlight
the need for parents and caregivers to take measures to prevent
exposure of secondhand smoke in children and underscore the need
for increasing consumer demand for cessation.
TOP

Cathy Backinger, Ph.D., Branch Chief, Tobacco Control Research Branch, Behavioral Research Program, National Cancer Institute
Dr. Backinger is Branch Chief of the Tobacco Control Research
Branch (TCRB), NCI, and a scientific Program Director for the
development and implementation of extramural behavioral and public
health research programs in the research areas of prevention and
cessation of tobacco use by youth, and smokeless tobacco. As Branch
Chief, she provides overall leadership for TCRB tobacco-related
initiatives and research, as well as dissemination of evidence-based
findings to prevent, treat, and control tobacco use. TCRB is working
toward a world free of tobacco use and related cancer and suffering.
Dr. Backinger joined NCI in 1998 as a Health Scientist.
Prior to joining NCI, Dr. Backinger was Director, Issues Management
Staff in the Office of Surveillance and Biometrics, Center for
Devices and Radiological Health, Food and Drug Administration
(FDA), Rockville, MD. She has also worked at the Centers for Disease
Control and Prevention and the Ohio Department of Health.
Dr. Backinger received a Ph.D. in Health Policy from the University
of Maryland, Baltimore County, an M.P.H. from the University of
Michigan, and a B.S. in Health Education from the Ohio State University.
Q1: National Cancer Institute recently released Monograph
19 in their Tobacco Control Monograph series. The report, "The
Role of the Media in Promoting and Reducing Tobacco Use," reaches
the government's strongest conclusion to date that tobacco marketing
and depictions of smoking in movies promote youth smoking. Can
you talk a little about the findings and recommendations of the
report and the impact on youth cessation?
One of the major conclusions of the monograph is that the total
weight of the evidence from cross-sectional, longitudinal, and
experimental studies indicates a causal relationship between exposure
to depictions of smoking in movies and youth smoking initiation.
The report found that depictions of cigarette smoking are pervasive
in the movies, occurring in three-quarters or more of contemporary
box-office hits, with Identifiable brand images appearing in about
one-third of movies. And, smoking prevalence among contemporary
movie characters is about 25 percent, almost twice the rate in
the 1970s and 80s. The monograph relied on the totality of evidence
from multiple studies using a variety of research designs and
methods to understand the effects of media on tobacco promotion
and tobacco control. Importantly, it is the first time that a
government report has demonstrated that smoking in the movies
is causally related to youth smoking initiation. Smoking in the
movies has implications for both prevention and cessation because
images of smoking in movies can influence both adolescent and
adult viewers' beliefs about social norms for smoking, beliefs
about the function and consequences of smoking, and personal intentions
to smoke.
Given what we now know, it will be important to address proactively
the influence of smoking in the movies. For example, research
indicates that anti-tobacco advertisements shown prior to movies
can counter the impact of their tobacco portrayals. And, we especially
need to ensure that the general public, particularly parents and
other care-givers, understand the effect watching smoking in movies
has on children.
Q2: The revised PHS Guideline recognizes the need to
address youth smoking and highlights, for the first time, that
counseling is an effective treatment for helping youth smokers
quit. Can you talk a little about this important milestone and
the role YTCC can play in increasing consumer demand among youth
and young adults?
The May 2008 PHS Clinical Practice Guideline, "Treating Tobacco
Use and Dependence," is an update of the 2000 guidelines, which
determined that counseling and behavioral interventions found
effective for adults should be considered for use with children
and adolescents. In 2000, the panel also found that clinicians
may consider using medications to treat adolescents if there was
evidence of nicotine dependence and a desire to quit tobacco use.
The panel achieved consensus on these recommendations, despite
the absence of randomized controlled trials, because of the clinical
importance of improving treatment for adolescents. The big news
is that, 8 years later, the 2008 update panel found that "counseling
has been shown to be effective in treatment of adolescent smokers."
I think that the advances we have made in youth smoking cessation
have been driven, in large part, by the efforts of YTCC and its
partner organizations.
Over the last 10 years, numerous studies have helped us sort
out many of the challenges of youth cessation, but there is more
research that is needed. For example, we need to expand behavioral
approaches and explore different intervention settings where youth
interact, as well as investigate whether cell phones, social networking
sites, or other new technologies can help us reach and engage
youth in smoking cessation. Also, only a small number of studies
have examined whether medications can help youth quit smoking;
we need to continue this line of investigation, especially as
new medications for adults are approved by the FDA. And, understanding
the impact on cessation of dual use of tobacco products such as
smoking and using smokeless tobacco is important. We still have
work to do to increase consumer demand among youth and young adults,
just as we do to increase demand among adults generally. The NTCC's
Consumer Demand Initiative has been making strides that will generate
new strategies for increasing the demand for and use of evidence-based
tobacco cessation products and services among many population
groups.
Q3: YTCC recently conducted a brief analysis of tobacco
cessation content in videos on YouTube that revealed that non-evidence-based
treatments are most often depicted positively while evidence-based
treatments, such as NRT and prescription medications, are often
depicted negatively. To follow-up on these initial findings, NCI
and YTCC are currently conducting a more rigorous and in-depth
analysis of the cessation content on YouTube. What is the potential
impact of the messages presented on new media channels, such as
YouTube, MySpace, Facebook, etc., on youth and young adult tobacco
use and cessation?
To build on the YTCC analysis, NCI performed a search of YouTube
by relevance and view count using the search terms, "quit smoking,"
"stop smoking," and "smoking cessation." While we are primarily
interested in tobacco cessation methods and the extent to which
they were evidence-based or not, we are also coding for source
of video, video setting, quality of video, and characteristics
of the primary person delivering the message. Our preliminary
analysis has found that videos tagged as "smoking cessation" were
likely to be produced by professional health organizations, TV
newsclips, and PSAs, and to describe evidence-based cessation
methods. In contrast, the majority of videos tagged as "stop smoking"
or "quit smoking" featured non-evidence-based methods. Multiple
cessation methods were mentioned in the majority of "stop smoking"
videos, yet only 9 of those methods were clearly evidence-based.
Hypnosis was the most frequent non-evidence-based method mentioned;
also featured were using snus as a cessation aid, "scare tactics,"
herbal supplements, reducing the body's acidity, an "emotional
freedom technique," biorhythms, and throwing away cigarettes.
As you might imagine, this analyses has been a fascinating project.
Both researchers and the tobacco control community need to pay
attention to the new technologies that youth and young adults
are engaged in. If you have not spent much time on YouTube, I
recommend checking out a random sample of smoking videos to get
a sense of the kinds of videos being posted. I think you will
find it eye opening!
Q4: You served as a co-facilitator at the YTCC course,
"Strategies for Reducing Tobacco Use among Young Adults" at the
2008 Summer Institute in Phoenix, AZ. What were some of the highlights
of the course?
It was exciting to interact with so many knowledgeable and dedicated tobacco control program staff. Over the 3 mornings of the course, we covered a wide range of topics including the unique population of young adults and young adult smokers, tobacco use patterns, tobacco industry marketing, evaluation considerations, prevention and cessation strategies, reaching and engaging young adults, and developing an action plan. The format provided participants time to interact, to talk about their own programs, and to get feedback in order to develop plans to intervene with young adults. A big highlight was having presenters from outside of tobacco control science; it is extremely useful for us to get outside of our own domains and listen to other perspectives. For example, we had a presentation from a marketing and communications firm that explained how food, clothing, and other companies reach young adults including understanding what magazines they read, what TV shows they watch, and what Internet sites they frequent. We also had a young adult presenter who shared her perspective on how we can engage young adults in interventions and programs. We are still in the early stages of developing effective prevention and cessation strategies specifically for young adults. I think the Summer Institute helped provide a framework to move forward.
Q5: The tobacco industry has been developing new products,
such as flavored products and novel smokeless products, to encourage
and sustain addiction. What has been the impact of this on cessation,
particularly youth cessation?
We do not yet know the extent to which youth and young adults use these products. However, we are very concerned about the potential of these products to appeal to youth and young adults because of their flavorings and their novelty. For example, a recent study of college students found that flavored cigarettes elicited higher positive expectancies about smoking compared with non-flavored cigarettes among nonsmokers, regular smokers, and those susceptible to smoking. Additionally, tobacco industry document research has found that cigarette companies added flavorings to cigarettes in order to increase their appeal to both youth and women. Some new smokeless tobacco products contain flavorings as well, but these products have not been studied as yet. In particular, we need to examine dual use of tobacco products - cigarettes and smokeless tobacco - in light of advertising encouraging smokeless tobacco use in situations where smoking is not permitted. While it is not clear what the impact of these products will be, it is important to monitor their use, especially their impact on initiation and cessation.
Q6: How did you get involved in tobacco control?
I began my career as a dental hygienist, before transitioning into public health. In the 1980s, I worked in the dental program at the Centers for Disease Control and Prevention (CDC), where I was involved in tobacco issues, particularly smokeless tobacco, because of its impact on oral health. While at CDC, I worked on an evaluation of the "Comprehensive Smokeless Tobacco and Health Education Act of 1985," and also developed and evaluated a smokeless tobacco prevention curriculum for Alaska Native schoolchildren. When I came to NCI in 1998, I returned to tobacco control because I really wanted to make a difference on this issue. Frankly, it is the public health issue that I am most passionate about.
Q7: What has been the most challenging aspect of your work in tobacco control?
Without a doubt the most challenging aspect of our work is the immense financial resources of the tobacco industry; in 2005 alone, the U.S. tobacco companies spent more than $13 billion to market and advertise their products. The words of the World Health Organization's Expert Committee on Tobacco Industry Documents (July 2000) bear repeating: "Tobacco use is unlike other threats to global health. Infectious diseases do not employ multinational public relations firms. There are no front groups to promote the spread of cholera. Mosquitoes have no lobbyists." Tobacco control researchers must better understand and counteract pro-tobacco messages. This will require a coordinated effort by local, state, national and international groups, from both the public and private sector. We can no longer address one issue at a time - like putting our finger in the dike and then running to fix a leak elsewhere. I know we are up to this challenge.
Q8: What has been the most rewarding aspect of your work
in tobacco control?
It has been the opportunity to work with so many knowledgeable and committed people from the U.S, and around the world, all of whom are dedicated to improving public health. The partnerships and collaborations we have formed to move tobacco control forward is inspiring. The whole is greater than the sum of the parts; when we work together, we are truly a force to be reckoned with.
Q9: What, in your opinion, have been the most important developments in tobacco control in the past year?
We find ourselves at an exciting time in tobacco control in many areas. As of September 2008, 160 countries are parties to the World Health Organization's Framework Convention on Tobacco Control - the first ever global public health treaty. In the U.S., legislation to provide the Food and Drug Administration authority to regulate tobacco products, if enacted, would certainly be a major development. I also think the movement to pass smoke-free policies, not only among U.S. states, but in countries around the world, is an enormously important accomplishment. Not only do these policies protect nonsmokers from secondhand smoke, they make it easier for smokers to quit, and help change social norms about smoking. And finally, the 2008 update of the PHS guidelines with evidence to support youth smoking cessation is definitely a major development.
Q10: What, in your opinion, is the most important challenge facing tobacco control in the year ahead?
I think there are several, but perhaps the most important is to maintain momentum and not lose ground. I think there is a perception that we have all the tools we need to address tobacco use. Certainly, we know a lot about what works, and this information should be disseminated and acted upon. But, there is much more we need to know. About one in five Americans is a current smoker, and we continue to have glaring disparities in tobacco use rates among different populations, which will eventually translate in to glaring disparities in tobacco-caused disease rates. Despite decades of work to prevent tobacco use by youth, about half of all students have tried smoking by the time of high school graduation. Additionally, we are faced with a constantly adapting and evolving tobacco industry. For all of these reasons, and many more, a vigorous research enterprise is needed.
TOP

Study Finds that Doctors Lack Smoking Cessation Training
Few doctors or other health-care providers have
enough smoking cessation training to help their patients quit
smoking, a U.S. study suggests.
It found that 87 percent to 93 percent of doctors
and other health-care workers receive less than five hours of
training on tobacco dependence, and less than 6 percent know the
U.S. Agency for Healthcare Research and Quality (AHRQ) treatment
guidelines for tobacco dependence, including the signs of nicotine
withdrawal. This lack of knowledge about treating tobacco dependence
may affect quit rates among smokers, suggested lead researcher
Virginia Reichert and colleagues at the North Shore-LIJ Health
System Center for Tobacco Control in Great Neck, NY.
They surveyed 322 prescribers (physicians, nurse
practitioners, or physician assistants) and 278 nonprescribers
(pharmacists, registered nurses, social workers, counselors, respiratory
therapists, and students).
The researchers found that 87 percent of prescribers
and 93 percent of nonprescribers received less than five hours
of tobacco-dependence training. Only 6 percent of prescribers
and 5 percent of nonprescribers knew the AHRQ treatment guidelines
for tobacco dependence.
The study also found only 16 percent of prescribers
and 8 percent of nonprescribers knew which U.S. Food and Drug
Administration-approved medications were over-the-counter and
which required a prescription.
The findings were to be presented at the American
College of Chest Physicians (ACCP) annual meeting, in Philadelphia.
"Without appropriate training in tobacco dependence
treatment, health- care providers may lack the knowledge and confidence
to help their patients quit smoking," Reichert said in an ACCP
news release. "Furthermore, providers may not recognize that tobacco
dependence is a chronic relapsing condition and become frustrated
when patients do not quit when advised to do so."
Previous studies have found that about 70 percent
of smokers want to quit but believe it will be too difficult without
assistance, and that smokers are 30 percent more likely to kick
the habit if they receive help from their health-care provider.
For more information, see web link:
The
Washington Post October 27, 2008
Smoking Cessation Interventions for Hospitalized Smokers: A Systematic Review
Hospital-sponsored stop-smoking programs for inpatients
that include follow-up counseling for longer than one month significantly
improve patients' ability to stay smoke-free. An analysis of clinical
trials of programs offered at hospitals around the world finds
that efforts featuring long-term support can increase participants'
chances of success by 65 percent. The study - led by Nancy Rigotti,
director of the Tobacco Research and Treatment Center at Massachusetts
General Hospital (MGH) - appears in the October 13 issue of Archives
of Internal Medicine and is one of several articles focused
on smoking.
"While nobody looks forward to a hospital stay,
it can really have an extra benefit for smokers" says Rigotti.
"But this is only if the hospital helps them quit with counseling
during and after their hospital stay. Hospitals really need to
step up to the plate and offer this type of service routinely,
and it also should be reimbursed by payers."
Entering the hospital poses a special challenge
for smokers because all U.S. hospitals are now smoke-free, but
it also can offer those ready to quit an important opportunity.
Both the inability to smoke during their hospital stay and a determination
to recover from their illness, particularly if it is tobacco-related,
can encourage smokers to begin a serious effort to kick the habit.
Many hospitals offer stop-smoking help to their patients, but
questions remain about whether those programs are successful.
The current study analyzed the results of 33 clinical trials of
hospital-based programs in nine countries conducted between 1999
and 2007.
Analyzing hospital-based efforts according to their
intensity - a single brief smoking-related contact, one or more
extended contacts during hospitalization, hospital contact plus
a month or less of post-discharge telephone support, and hospital
contact followed by more than a month of post-discharge support
- revealed that only programs with the highest intensity level
were more successful than usual care in helping patients quit
for six months or longer.
Including nicotine replacement products further
increased patients' quit rates - probably by both relieving nicotine
withdrawal symptoms and helping patients stay off cigarettes once
they leave the hospital, the researchers note - but data were
not sufficient to assess the impact of pharmaceuticals like bupropion
and varenicline. Although the success rate for patients admitted
with cardiovascular disease was a bit higher, intensive counseling
was successful for all hospitalized smokers, regardless of their
diagnosis.
The information analyzed in this study came from
the trial register of the Cochrane Tobacco Addiction Review Group,
which is supported by the National Health Service of the United
Kingdom. Additional support came from the U.S. National Heart,
Lung and Blood Institute. The study's co-authors are Marcus Munafo,
University of Bristol, England, and Lindsay Stead, Cochrane Tobacco
Addiction Review Group.
For more information, see web link:
Harvard
University Gazette October 16, 2008
Smell Of Smoke Does Not Trigger Relapse In Quitters, New Research Shows
Research into tobacco dependence published in the
November issue of Addiction, has shown that recent ex-smokers
who find exposure to other people's cigarette smoke pleasant are
not any more likely to relapse than those who find it unpleasant.
Led by Dr Hayden McRobbie and Professor Peter Hajek
of the Tobacco Dependence Research Unit at Barts and The London
School of Medicine and Dentistry, researchers examined the hypothesis
that those who find the smell of smoke pleasant are more likely
to relapse than those who have a neutral or negative reaction
to it. Surprisingly, they concluded that finding the smell of
other people's cigarettes pleasant does not make abstaining smokers
any more likely to relapse.
The researchers studied a group of over a thousand
smokers receiving smoking cessation treatment at the East London
Smokers Clinic. During their six weeks of treatment (two weeks
prior to quitting and four weeks afterwards) the smokers completed
a weekly questionnaire that measured the severity of their withdrawal
discomfort, and also asked them to rate how pleasant they found
the smell of other people's cigarettes during the past week.
The results showed that during their first week
of abstinence, 23 percent of respondents found the smell of other
people's cigarette smoke pleasant. Finding the cigarette smoke
pleasant was not related to smoking status in the following week.
Lead author Dr Hayden McRobbie says, "Recent quitters
can be reassured that finding the smell of cigarette smoke pleasant
is not likely to lead them back to smoking."
For more information, see web link:
ScienceDaily
October 18, 2008
Men Who Never Smoke Live Longer, Better Lives Than Heavy Smokers
Health-related quality of life appears to deteriorate
as the number of cigarettes smoked per day increases, even in
individuals who subsequently quit smoking, according to a report
in the October 13 issue of Archives of Internal Medicine.
Smoking has been shown to shorten men's lives between
seven and 10 years, according to background information in the
article. It also has been linked to factors that may reduce quality
of life, including poor nutrition and lower socioeconomic status.
Arto Y. Strandberg, M.D., of the University of Helsinki,
and colleagues followed 1,658 white men born between 1919 and
1934 who were healthy at their first assessment, conducted in
1974. Participants were mailed follow-up questionnaires in 2000
that assessed their current smoking status, health and quality
of life. Deaths were tracked through Finnish national registers.
During the 26-year follow-up period, 372 (22.4 percent) of the
men died. Those who had never smoked lived an average of 10 years
longer than heavy smokers (more than 20 cigarettes per day). Non-smokers
also had the best scores on all health-related quality of life
measures, especially those associated with physical functioning.
Physical health deteriorated at an increasing rate as the number
of cigarettes smoked per day increased, with heavy smokers experiencing
a decline equivalent to 10 years of aging.
"Although many smokers had quit smoking between
the baseline investigation in 1974 and the follow-up examination
in 2000, the effect of baseline smoking status on mortality and
the quality of life in old age remained strong," the authors write.
"In all, the results presented here are troubling for those who
were smoking more than 20 cigarettes daily 26 years earlier; in
spite of the 68.9 percent cessation rate during follow-up, 44.1
percent of the originally heavy smokers had died, and those who
survived to the mean [average] age of 73 years had a significantly
lower physical health-related quality of life than never-smokers."
The findings may add to the view of smoking as a
burden on society and might also encourage individual smokers
to quit, the authors note. "The argument of better quality of
life may be especially meaningful for the aging smoker but, as
our results show, for the best health-related quality of life,
the habit should not be started at all," they write. "The highly
addictive nature of nicotine is revealed by the persistence of
the smoking habit in spite of the declining health-related quality
of life among older heavy smokers. For those not able to quit
smoking, reduction may also be beneficial because mortality [death]
and health-related quality of life showed a dose-dependent trend
according to the number of cigarettes smoked daily."
For more information, see web link:
ScienceDaily
October 14, 2008
A Randomized Trial of a Pay-for-Performance Program Targeting Clinician Referral to a State Tobacco Quitline
A pay-for-performance program may increase referrals
to tobacco quitline services, particularly among clinics who have
not previously participated in quality improvement activities.
A study, appearing in the October 13 issue of the
Archives of Internal Medicine, looked at programs that
tie physician pay to the quality of care. The key measure was
clinics' referrals of patients in Minnesota to a tobacco quit
line. Researchers compared clinics that were paid bonuses for
making such referrals to clinics that didn't have a financial
incentive.
Lawrence C. An, M.D., of the University of Minnesota,
Minneapolis, and colleagues randomly assigned 24 primary care
clinics to participate in a program offering $5,000 for 50 quitline
referrals and $25 for each referral beyond the initial 50.
Between Sept. 1, 2005, and June 31, 2006, these
clinics in the pay-for-performance program referred 11.4 percent
of eligible smokers, compared with 4.2 percent among 25 clinics
offering usual care. "Quitlines are widely available, and application
of pay-for-performance strategies to encourage health care provider
referral should be strongly considered by health care organizations
seeking to reduce the health and economic burden of tobacco-related
disease," the authors write.
The researchers also noted some important factors
for success beyond cold cash. For one, Minnesota health plans
collaborated to make the referral process easy for the clinics.
The clinics were also rewarded regardless of what health plan
their patients belonged to, meaning that they could make the same
recommendation to all smokers.
For more information, see web link:
Archives
of Internal Medicine Vol. 168 No. 18, October 13, 2008
Predictors of Smoking Cessation After a Myocardial Infarction The Role of Institutional Smoking Cessation Programs in Improving Success
Hospital-based smoking cessation programs, along
with referrals to cardiac rehabilitation, appear to be associated
with increased rates of quitting smoking following heart attack.
Nazeera Dawood, M.D., M.P.H., at Emory University
School of Medicine, Atlanta, and colleagues found that individual
counseling after a heart attack is not particularly effective
at getting patients to quit smoking. Hospital-based smoking-cessation
programs, as well as referral to cardiac rehabilitation, are much
more successful.
Dawood and his colleagues enrolled patients with
myocardial infarction (heart attack) from 19 US centers participating
in the Prospective Registry Evaluating Outcomes After Myocardial
Infarction Events and Recovery (PREMIER) between January 2003
and June 2004. Smoking behavior was assessed by self-report during
hospitalization and six months after MI.
Among 834 patients who smoked at the time of MI
hospitalization, 639 were interviewed and reported their smoking
habits at six months post-MI. Of these, 297 (46 percent) were
not smoking at six months.
Ten of the 19 hospitals offered smoking-cessation
programs. While those who did and did not quit smoking were equally
likely to have had medical-chart-based individual-level counseling
to stop smoking (75 percent and 72 percent respectively), those
who did quit were significantly more likely to be admitted to
a hospital offering smoking-cessation programs (69 percent vs
56 percent). And those who stopped smoking were also more likely
to have been referred to cardiac rehabilitation at discharge (63
percent vs 47 percent).
"These findings extend the current understandings
of smoking habits after an MI and have important implications
for current quality-assessment efforts," say the researchers.
For more information, see web link:
Archives
of Internal Medicine Vol. 168 No. 18, October 13, 2008
Do 'Light' Cigarettes Deliver Less Nicotine To The Brain Than Regular Cigarettes?
For decades now, cigarette makers have marketed
so-called light cigarettes - which contain less nicotine than
regular smokes - with the implication that they are less harmful
to smokers' health. A new UCLA study shows, however, that they
deliver nearly as much nicotine to the brain.
Reporting in the current online edition of the
International Journal of Neuropsychopharmacology, UCLA psychiatry
professor Dr. Arthur L. Brody and colleagues found that low-nicotine
cigarettes act similarly to regular cigarettes, occupying a significant
percentage of the brain's nicotine receptors.
Light cigarettes have nicotine levels of 0.6 to
1 milligrams, while regular cigarettes contain between 1.2 and
1.4 milligrams.
The researchers also looked at de-nicotinized cigarettes,
which contain only a trace amount of nicotine (0.05 milligrams)
and are currently being tested as an adjunct to standard smoking-cessation
treatments. They found that even that low a nicotine level is
enough to occupy a sizeable percentage of receptors.
Fifteen smokers participated in the study. Each
was given positron emission tomography (PET) scans, a brain-imaging
technique that uses minute amounts of radiation-emitting substances
to tag specific molecules. In this case, the tracer was designed
to bind to the nicotine receptors in the brain.
The researchers could then measure what percentage
of the tracer was displaced by nicotine when the research subjects
smoked. In total, 24 PET scans were taken of participants' brains
before and after three different conditions: not smoking, smoking
a de-nicotinized cigarette and smoking a low-nicotine cigarette.
The PET data showed that smoking a de-nicotinized
cigarette and a low-nicotine cigarette occupied 26 percent and
79 percent of the receptors, respectively, which was very close
to what the researchers had originally estimated.
"The two take-home messages are that very little
nicotine is needed to occupy a substantial portion of brain nicotine
receptors," Brody said, "and cigarettes with less nicotine than
regular cigarettes, such as 'light' cigarettes, still occupy most
brain nicotine receptors. Thus, low-nicotine cigarettes function
almost the same as regular cigarettes in terms of brain nicotine-receptor
occupancy.
"It also showed us that de-nicotinized cigarettes
still deliver a considerable amount of nicotine to the brain.
Researchers, clinicians and smokers themselves should consider
that fact when trying to quit."
For more information, see web link:
ScienceDaily September 29, 2008
TOP

Panel Calls for Vaccine for Adult Smokers
For the first time, an influential government panel
is recommending a vaccination specifically for smokers. The panel
decided recently that adult smokers under 65 should get pneumococcal
vaccine. The shot -- already recommended for anyone 65 or older
-- protects against bacteria that cause pneumonia, meningitis
and other illnesses.
Federal officials usually adopt recommendations
made by the panel, the Advisory Committee on Immunization Practices.
The vote means more than 31 million adult smokers probably will
soon be called on to get the shot.
Studies have shown that smokers are about four times
more likely than nonsmokers to suffer pneumococcal disease. Also,
the more cigarettes someone smokes each day, the higher the odds
they'll develop the illnesses.
Why smokers are more susceptible is not known for
sure, but some scientists believe it has to do with smoking-caused
damage that allows the bacteria to more easily attach to the lungs
and windpipe, said Dr. Pekka Nuorti, a medical epidemiologist
with the Centers for Disease Control and Prevention.
Pneumococcal infections are considered the top killer
among vaccine-preventable diseases. It's a common complication
of influenza, especially in the elderly, and is considered responsible
for many of the 36,000 annual deaths attributed to flu.
The committee voted 11 to 3 to pass the recommendation,
with one member abstaining. The panel also added a call for smoking
cessation counseling.
Some members said it might be more cost effective
to recommend the vaccine for smokers who were at least age 40,
because pneumococcal disease is relatively uncommon in younger
smokers.
For more information, see web link:
The
New York Times October 22, 2008
Smoke Stinks
in a Slow Real Estate Market: 76 Percent of Potential Home Buyers
Say Cigarette Smoke Odor Would Be a Deal Breaker
As "For Sale" signs dot yards throughout Florida,
plummeting sales and home prices and soaring foreclosures signal
that the housing crisis continues to deepen. When the real estate
market is competitive, a home with a pungent odor such as cigarettes
can make or break the deal. According to a 2008 Home Features
Survey done by Zip Realty, 76 percent of respondents say that
bad odors, such as cigarette smoke, would sway their decision
against purchasing a home. Tobacco Free Florida wants to help
Floridians maintain their edge in a competitive market and live
healthier lives.
The stale, lingering odor of cigarette smoke seeps
into and sticks on furniture, carpets, walls, curtains and just
about every surface it comes in contact with. Household cleaners
alone won't get the job done, therefore professionals need to
be hired to deep clean the stubborn odors and remove stains. Smokers
incur extra costs when selling a house that non-smokers do not.
Homes may require new paint and professional carpet and drapery
cleaning. For an average sized home this could run a homeowner
approximately $3,000 in additional expenses.
Think smoking outside is the answer? "It is not,"
says Kim Berfield, Deputy Secretary of the Florida Department
of Health. "Smoking outside helps reduce tobacco odor, but does
not eliminate it. Clothes absorb the smell, dragging it back into
the home and undoubtedly finding its way to closets and drawers.
Quitting smoking is the only way to completely rid a home of the
smell."
In addition to the effect that cigarette smoke can
have to a home's interior, smoking inside puts others at risk
of the dangers of second-hand smoke. There is no safe level of
exposure to secondhand smoke and there is no ventilation (i.e.,
an open window) that can eliminate the exposure.
For more information, see web link:
PRNewsWire
October 21, 2008
Virginia Ad Campaign: No Matter the Time of Day, Lung Cancer Shouldn't be on the Menu
Secondhand smoke is dangerous no matter the time
of day, and Virginia needs a law requiring restaurants to be smoke-free
at all times and not just at certain times as some leaders have
proposed, according to a newspaper advertising campaign launched
today by a coalition of public health organizations.
The newspaper ad states, "No matter the time of
day, lung cancer shouldn't be on the menu." The advertisement
further states, "All Virginians deserve the right to breathe clean
air. Every hour. Every day." To view the ad, go to http://www.tobaccofreekids.org/campaign/va2008/everyhour.pdf
News reports indicate that some state officials
are considering a plan that would still allow smoking in Virginia
restaurants after 10 p.m. Leading public health organizations
have criticized the plan, which would be difficult and costly
to enforce and - most importantly - would continue to put workers'
and customers' health at risk. Secondhand smoke contains more
than 4,000 chemicals, including 69 known to cause cancer - and
those toxins can linger long after the last cigarette is put out.
Secondhand smoke is a proven cause of lung cancer, heart disease
and other serious illnesses.
"No one should have to risk their health in order
to earn a paycheck or enjoy a night out in a restaurant," said
William V. Corr, Executive Director of the Campaign for Tobacco-Free
Kids. "Virginians deserve a real smoke-free law that protects
all workers and customers at all times of the day and night. Everyone
has the right to breathe clean, smoke-free air, free from the
proven dangers of secondhand smoke."
Virginians strongly support a comprehensive smoke-free
law. In a January 2008 poll, 75 percent of Virginia voters said
they support a statewide law that makes all restaurants completely
smoke-free. And 88 percent of voters agreed that all workers in
Virginia should be protected from exposure to secondhand smoke
in the workplace.
The ad campaign is sponsored by Virginians for a
Healthy Future, American Lung Association of Virginia, American
Cancer Society, American Heart Association, Robert Wood Johnson
Foundation, Americans for Nonsmokers' Rights and Campaign for
Tobacco-Free Kids.
For more information, see web link:
MarketWatch
October 14, 2008
More Colleges Stamp Out Smoking
College campuses are going smoke-free in rapidly
growing numbers across the USA.
More than 140 campuses now are completely smoke-free,
more than triple the number that had banned smoking as recently
as March 2007, said Frieda Edgette, of the lobbying group Americans
for Nonsmokers' Rights.
An additional 30 campuses are smoke-free with a
few exceptions, such as designated smoking outdoor areas, and
at least 500 campuses have smoke-free policies in residential
housing, she said.
The most recent major development came last month,
when the Pennsylvania State System of Higher Education (PASSHE)
announced a smoking ban at all state-owned universities, after
the state passed a ban prohibiting smoking in most work and public
places in June. That made the state's 14 universities, attended
by more than 110,000 students, smoke-free.
"The evidence and recognition that secondhand smoke
is a really big risk to health" is a major reason for the increase,
said Erika Sward, the American Lung Association's director of
national advocacy.
PASSHE spokesman Ken Marshall said the system examined
the state law and decided to ban smoking both indoors and outdoors
on its campuses.
"We hold events and classes outside, so we thought
it was appropriate to ban outdoor smoking," he said.
Many of the campuses that have gone smoke-free in
the past two years have been community and smaller colleges and
universities, Edgette said. In addition to Pennsylvania, the latest
include Bergen (County, NJ) Community College, Montgomery (MD)
College, Fullerton (CA) College, the University of North Dakota
and Indiana University-Purdue University Indianapolis.
For more information, see web link:
USAToday
October 13, 2008
The National Cancer Institute Receives CEO Cancer Gold Standard™ Accreditation
The National Cancer Institute (NCI) was recently
accredited with the CEO Cancer Gold Standard™ certification. NCI
joins twenty six other organizations, including two NCI-designated
Cancer Centers, that have achieved Gold Standard accreditation,
recognizing their efforts to meet an exceptionally high standard
of cancer prevention, screening and care guidelines for their
employees and family members.
William C. Weldon, chairman and chief executive
officer of Johnson & Johnson chairs the CEO Roundtable on Cancer,
the nonprofit organization of cancer-fighting CEOs that created
the CEO Cancer Gold Standard™, in collaboration with the American
Cancer Society, NCI-designated comprehensive cancer centers and
leading corporate health professionals.
"It is both appropriate and inspirational that the
preventative health and wellness guidelines and unparalleled cancer
care for which the National Cancer Institute and its director,
Dr. John Niederhuber stand for are provided for NCI's own employees
and their family members who are on the frontlines of our nation's
battle against cancer each and every day," said Weldon.
The CEO Cancer Gold Standard™, calls for companies
to evaluate their benefits and culture and take extensive, concrete
actions in five key areas of health and wellness to fight cancer
in the workplace. To earn Gold Standard accreditation, a company
must establish programs to reduce cancer risk by discouraging
tobacco use and encouraging physical activity, healthy diet and
nutrition; detect cancer at its earliest stages; and provide access
to quality care, including the availability of clinical trials.
The NCI's accreditation is coincident with the implementation
of a tobacco-free policy on the entire National Institutes of
Health (NIH) campus in Bethesda, MD, where the NCI is headquartered.
NCI will increase availability to tobacco cessation programs for
its employees and their families and support increased efforts
through the HealthierFeds program, to encourage physical activity,
nutritious diet, disease prevention, and overall healthy decision-making
for federal government employees.
The most recent President's Cancer Panel report,
"Promoting Healthy Lifestyles: Policy, Program, and Personal Recommendations
for Reducing Cancer Risk," identified the CEO Cancer Gold Standard™
as an initiative that is helping reverse negative, unhealthy lifestyle
trends and creating hope in the fight against cancer for America's
workers and their families.
Joining NCI in this workplace-based effort to eliminate
cancer as a public health threat are: American Cancer Society,
American Legacy Foundation, AstraZeneca, C-Change, Duke Medicine,
Edelman, Enzon Pharmaceuticals, GHI, GlaxoSmithKline, Jenner &
Block, Johnson & Johnson, The Lance Armstrong Foundation, MD Anderson
Cancer Center, H. Lee Moffitt Cancer Center and Research Institute,
Novartis, OSI Pharmaceuticals, Pfizer, PhRMA, PPD, Quintiles Transnational,
SAS Institute, The University of North Dakota, US Oncology, Valeant
Pharmaceuticals, Virtua Health and The Wistar Institute.
For more information, see web link:
MarketWatch
October 1, 2008
North Carolina Health and Wellness Trust Fund Announces 'Breathe Easy, Live Well' Program
The North Carolina Health and Wellness Trust Fund
(HWTF) announces the creation of a new statewide tobacco cessation
program for mental health consumers called "Breathe Easy, Live
Well." Approximately 70 percent of individuals with serious mental
illness smoke cigarettes, and individuals with mental illness
or addiction consume nearly half of all cigarettes purchased in
the United States.
The program, which will be implemented in psychosocial
treatment centers across the state, aims to reduce the harmful
effects that tobacco has on individuals with mental illness by
providing them with equal access to smoke-free environments and
cessation programs, in addition to increasing their awareness
about overall wellness.
The project is funded by the HWTF as part of its
overall tobacco cessation initiative. To date, HWTF has spent
$54.3 million to address tobacco use in the state since its efforts
began in 2003.
"The NC Health and Wellness Trust Fund is committed
to reducing the health effects of tobacco use in our state for
all populations," said Lt. Governor Bev Perdue, HWTF chair. "Through
this initiative, the Commission is intensifying its efforts to
reach out to this particularly vulnerable population with specialized
services designed to better meet their unique needs."
HWTF has awarded $505,000 to the NC Evidence Based
Practice Center, part of Southern Regional AHEC, to pilot the
program in mental health community/day treatment centers, also
known as clubhouses.
The first four pilot programs include Adventure
House in Shelby, Atlantic House in Morehead City, Sanctuary House
in Greensboro, and Threshold Clubhouse in Durham.
The clubhouses are non-profit, psychosocial rehabilitation
programs serving North Carolina adults with severe and persistent
mental illness. The clubhouses will begin training in November/December
2008, and wellness and cessation courses will launch in January
2009. For more information, please visit http://www.healthwellnc.com.
For more information, see web link:
The
Raleigh Chronicle September 26, 2008
TOP

Funding
Opportunities
- Testing
Tobacco Products Promoted to Reduce Harm, PA-07-174 (R01s).
Expires May 2, 2009.
- Testing
Tobacco Products Promoted to Reduce Harm, PA-06-361 (R21s).
Expires March 6, 2009.
- Improving
Effectiveness of Smoking Cessation Interventions and Programs
in Low Income Adult Populations, RFA-CA-08-022 (R01). Sponsor:
National Cancer Institute & National Institute on Drug Abuse,
NIH, DHHS.
- Improving
Effectiveness of Smoking Cessation Interventions and Programs
in Low Income Adult Populations, RFA-CA-08-023 (R21). Sponsor:
National Cancer Institute & National Institute on Drug Abuse,
NIH, DHHS.
-
Independent Scientist Award (K02) Sponsor: National Institutes
of Health (multiple institutes), DHHS.
- Health
Promotion Among Racial and Ethnic Minority Males, PA-07-421
(R21), Sponsor: National Institutes of Health (multiple institutes),
DHHS.
- Reducing
Health Disparities Among Minority and Underserved Children,
PA-07-391 (R21). Sponsor: National Institutes of Health (multiple
institutes), DHHS.
Call
for Papers/Abstracts
Conferences
and Trainings
TOP
|